Annual FCF
-$89.67 M
-$13.22 M-17.29%
April 30, 2024
Summary
- As of February 8, 2025, KALV annual free cash flow is -$89.67 million, with the most recent change of -$13.22 million (-17.29%) on April 30, 2024.
- During the last 3 years, KALV annual FCF has fallen by -$59.42 million (-196.41%).
- KALV annual FCF is now -1082.08% below its all-time high of $9.13 million, reached on April 30, 2018.
Performance
KALV Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$39.84 M
+$461.00 K+1.14%
October 31, 2024
Summary
- As of February 8, 2025, KALV quarterly free cash flow is -$39.84 million, with the most recent change of +$461.00 thousand (+1.14%) on October 31, 2024.
- Over the past year, KALV quarterly FCF has dropped by -$24.62 million (-161.67%).
- KALV quarterly FCF is now -242.11% below its all-time high of $28.04 million, reached on January 31, 2018.
Performance
KALV Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$123.06 M
-$19.81 M-19.19%
October 31, 2024
Summary
- As of February 8, 2025, KALV TTM free cash flow is -$123.06 million, with the most recent change of -$19.81 million (-19.19%) on October 31, 2024.
- Over the past year, KALV TTM FCF has dropped by -$33.38 million (-37.23%).
- KALV TTM FCF is now -861.02% below its all-time high of $16.17 million, reached on January 31, 2018.
Performance
KALV TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
KALV Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -17.3% | -161.7% | -37.2% |
| 3 y3 years | -196.4% | -100.2% | -117.4% |
| 5 y5 years | -139.5% | -402.6% | -184.9% |
KALV Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -196.4% | at low | -328.3% | +1.1% | -94.5% | at low |
| 5 y | 5-year | -196.4% | at low | -1003.7% | +1.1% | -306.8% | at low |
| alltime | all time | -1082.1% | at low | -242.1% | +1.1% | -861.0% | at low |
KalVista Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2024 | - | -$39.84 M(-1.1%) | -$123.06 M(+19.2%) |
| Jul 2024 | - | -$40.30 M(+164.7%) | -$103.24 M(+15.1%) |
| Apr 2024 | -$89.67 M(+17.3%) | -$15.23 M(-45.0%) | -$89.67 M(-7.7%) |
| Jan 2024 | - | -$27.68 M(+38.2%) | -$97.15 M(+23.3%) |
| Oct 2023 | - | -$20.03 M(-25.1%) | -$78.78 M(-1.0%) |
| Jul 2023 | - | -$26.74 M(+17.8%) | -$79.53 M(+4.0%) |
| Apr 2023 | -$76.46 M(-3.3%) | -$22.70 M(+144.0%) | -$76.46 M(-5.2%) |
| Jan 2023 | - | -$9.30 M(-55.2%) | -$80.63 M(-5.8%) |
| Oct 2022 | - | -$20.79 M(-12.2%) | -$85.59 M(+1.0%) |
| Jul 2022 | - | -$23.66 M(-12.0%) | -$84.70 M(+7.1%) |
| Apr 2022 | - | -$26.88 M(+88.4%) | -$79.06 M(+25.0%) |
| Apr 2022 | -$79.06 M(+161.3%) | - | - |
| Jan 2022 | - | -$14.27 M(-28.3%) | -$63.27 M(+11.8%) |
| Oct 2021 | - | -$19.90 M(+10.4%) | -$56.60 M(+26.7%) |
| Jul 2021 | - | -$18.02 M(+62.7%) | -$44.66 M(+47.6%) |
| Apr 2021 | -$30.25 M(-32.8%) | -$11.08 M(+45.8%) | -$30.25 M(-4.9%) |
| Jan 2021 | - | -$7.60 M(-4.6%) | -$31.80 M(-14.8%) |
| Oct 2020 | - | -$7.96 M(+120.6%) | -$37.31 M(+0.1%) |
| Jul 2020 | - | -$3.61 M(-71.4%) | -$37.27 M(-17.2%) |
| Apr 2020 | -$45.04 M(+20.3%) | -$12.63 M(-3.7%) | -$45.04 M(+4.3%) |
| Jan 2020 | - | -$13.11 M(+65.4%) | -$43.20 M(+5.5%) |
| Oct 2019 | - | -$7.93 M(-30.3%) | -$40.96 M(-2.6%) |
| Jul 2019 | - | -$11.37 M(+5.4%) | -$42.04 M(+12.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Apr 2019 | -$37.45 M(-510.1%) | -$10.79 M(-0.8%) | -$37.45 M(+11.1%) |
| Jan 2019 | - | -$10.88 M(+20.8%) | -$33.70 M(-746.2%) |
| Oct 2018 | - | -$9.01 M(+32.9%) | $5.21 M(-24.6%) |
| Jul 2018 | - | -$6.78 M(-3.7%) | $6.91 M(-24.3%) |
| Apr 2018 | $9.13 M(-138.4%) | -$7.04 M(-125.1%) | $9.13 M(-43.5%) |
| Jan 2018 | - | $28.04 M(-483.6%) | $16.17 M(-236.2%) |
| Oct 2017 | - | -$7.31 M(+60.4%) | -$11.87 M(+92.2%) |
| Jul 2017 | - | -$4.56 M(+182.1%) | -$6.17 M(-69.7%) |
| Apr 2017 | -$23.80 M(+80.7%) | - | - |
| Sep 2016 | - | -$1.62 M(-77.9%) | -$20.37 M(-15.4%) |
| Jun 2016 | - | -$7.32 M(+39.0%) | -$24.08 M(+3.4%) |
| Apr 2016 | -$13.17 M(-40.8%) | - | - |
| Mar 2016 | - | -$5.27 M(-14.5%) | -$23.28 M(+4.7%) |
| Dec 2015 | -$22.24 M(+242.5%) | -$6.16 M(+15.7%) | -$22.24 M(+8.5%) |
| Sep 2015 | - | -$5.33 M(-18.3%) | -$20.49 M(+11.4%) |
| Jun 2015 | - | -$6.52 M(+54.2%) | -$18.39 M(+32.5%) |
| Apr 2015 | -$6.49 M(-43.1%) | - | - |
| Mar 2015 | - | -$4.23 M(-4.2%) | -$13.89 M(+21.7%) |
| Dec 2014 | -$11.41 M(+134.0%) | -$4.41 M(+36.6%) | -$11.41 M(+63.1%) |
| Sep 2014 | - | -$3.23 M(+60.5%) | -$7.00 M(+85.7%) |
| Jun 2014 | - | -$2.01 M(+14.7%) | -$3.77 M(+114.7%) |
| Mar 2014 | - | -$1.75 M | -$1.75 M |
| Dec 2013 | -$4.88 M(+153.2%) | - | - |
| Dec 2012 | -$1.93 M | - | - |
FAQ
- What is KalVista Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals annual FCF year-on-year change?
- What is KalVista Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals quarterly FCF year-on-year change?
- What is KalVista Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals TTM FCF year-on-year change?
What is KalVista Pharmaceuticals annual free cash flow?
The current annual FCF of KALV is -$89.67 M
What is the all time high annual FCF for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high annual free cash flow is $9.13 M
What is KalVista Pharmaceuticals annual FCF year-on-year change?
Over the past year, KALV annual free cash flow has changed by -$13.22 M (-17.29%)
What is KalVista Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of KALV is -$39.84 M
What is the all time high quarterly FCF for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high quarterly free cash flow is $28.04 M
What is KalVista Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, KALV quarterly free cash flow has changed by -$24.62 M (-161.67%)
What is KalVista Pharmaceuticals TTM free cash flow?
The current TTM FCF of KALV is -$123.06 M
What is the all time high TTM FCF for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high TTM free cash flow is $16.17 M
What is KalVista Pharmaceuticals TTM FCF year-on-year change?
Over the past year, KALV TTM free cash flow has changed by -$33.38 M (-37.23%)